Trials / Completed
CompletedNCT01729689
Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers
Intervention Development for Anxiety in Metastatic NSCLC Patients and Their Caregivers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This pilot clinical trial studies cognitive behavioral therapy in treating anxiety in patients with stage IV non-small cell lung cancer and their caregivers. Cognitive behavioral therapy may reduce anxiety and improve the well-being and quality of life of patients who have stage IV non-small cell lung cancer and their caregivers.
Detailed description
PRIMARY OBJECTIVES: I. To identify, through both quantitative and qualitative methods, clinical correlates of anxiety and points of intervention to reduce anxiety in patients with late-stage lung cancer and their primary caregivers. II. To apply these findings to develop a brief dyadic intervention based on Cognitive Behavioral Therapy (CBT) to reduce anxiety in late-stage lung cancer patients and their primary caregivers. III. To evaluate the feasibility and acceptability of the pilot intervention through number of completed visits and assessment pre- and post- intervention. OUTLINE: Participants undergo cognitive behavioral therapy over 1 hour once weekly for a total of 6 sessions. Sessions are tailored to patient and caregiver cognitions and approach and avoidance behaviors. After completion of study treatment, participants are followed up at 1 week.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | counseling intervention | Undergo cognitive behavioral therapy |
| OTHER | questionnaire administration | Ancillary studies |
| PROCEDURE | quality-of-life assessment | Ancillary studies |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2013-11-01
- Completion
- 2013-11-01
- First posted
- 2012-11-20
- Last updated
- 2014-08-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01729689. Inclusion in this directory is not an endorsement.